XB-PHENO-27384
Xla Wt + smarce1 MO, Hutlet B and Schlosser G (2025)
| Experiment + Assay: |
Xla Wt + smarce1 MO +
NF13-14 (in situ hybridization)
|
| Manipulations: |
| Manipulation Type |
Reagent |
Target Gene |
Stage |
Treatment Area |
|
morpholino injection
|
|
smarce1
|
NF stage 5 (16-cell)
|
|
|
| Conditions: |
| Assay Type |
Assay Stages |
Antibody |
|
in situ hybridization
|
NF stage 13
to NF stage 14
|
|
|
|
|
Expression Phenotypes (10):
|
|
decreased amount
eya1.L
expression in preplacodal ectoderm
|
|
decreased amount
foxd3.L
expression in cranial neural crest
|
|
decreased amount
neurod1.L
expression in non-neural ectoderm
|
|
decreased amount
neurog1.L
expression in non-neural ectoderm
|
|
decreased amount
neurog2.L
expression in non-neural ectoderm
|
|
decreased amount
six1.L
expression in preplacodal ectoderm
|
|
increased amount
sox3.L
expression in neural plate
|
|
mislocalised
sox3.L
expression in non-neural ectoderm
|
|
decreased amount
tubb2b.L
expression in neuroectoderm
|
|
absent
tubb2b.L
expression in non-neural ectoderm
|
|
